Genotyping Assay : Increasing Demand Genotyping & Sequencing Services
<p>The major factors that are expected to be driving thegenotyping assay marketare technological advancements and the decreasing prices of DNA sequencing. The increasing incidence of genetic diseases and rising awareness of personalized medicine, growing importance of genotyping in drug development, and the increasing demand for bioinformatics solutions in data analysis are also expected to promote market growth in the coming years. The objective of the report is to define, describe, and forecast the genotyping assay market size based on product & service, technology, application, end user, and region.</p>
<p>According to the new market research report “Genotyping Assay Market by Technology (PCR, Sequencing, Microarray, Electrophoresis, MALDI-TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), and Product – Global Forecast to 2023“, published by MarketsandMarkets™, the Genotyping Assay Market is expected to reach USD 31.9 billion by 2023 from an estimated USD 11.8 billion in 2018, at a CAGR of 22.0%.</p>
<p><br />Browse in-depth TOC on “Genotyping Assay Market“</p>
<p><br />219 – Tables</p>
<p><br />53 – Figures</p>
<p><br />280 – Pages</p>
<p> <br />Download PDF Brochure: <a href="https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249958595">https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249958595</a></p>
<p><br />Based on product, the market is divided into reagents & kits, genotyping services, instruments, and bioinformatics. The easy accessibility to a wide range of reagents and need for genotyping in various applications (such as assessing drug efficacy & safety, cutting down cost and time required for clinical development, personalizing the treatments for chronic diseases, and developing good breeds of animals and plants) have contributed to the high and repetitive consumption of reagents and kits as consumables in various genotyping applications.<br />Request for sample pages @<a href="https://www.marketsandmarkets.com/requestsampleNew.asp?id=249958595">https://www.marketsandmarkets.com/requestsampleNew.asp?id=249958595</a></p>
<p><br />The prominent players in the Genotyping Assay Market are Thermo Fisher Scientific (US), Illumina (US), QIAGEN (Netherlands), Agilent Technologies (US), Danaher Corporation (US), Roche Diagnostics (Switzerland), GE Healthcare (US), Fluidigm Corporation (US), PerkinElmer (US), Eurofins Scientific (Luxembourg), Bio-Rad Laboratories (US), Pacific Biosciences of California (US), GENEWIZ (US), and Integrated DNA Technologies (US).</p>
<p> </p>